Activity monitoring using a mHealth device and correlations with psychopathology in patients with chronic schizophrenia

Psychiatry Research

Volumn 246, Issue , 2016, Pages 712-718

  Shin, Seunghwan ^a   Yeom, Chan Woo ^a   Shin, Cheolmin ^a   Shin, Jae Hyun ^a   Jeong, Jae Hoon ^a   Shin, Jung Uk ^a   Lee, Young Ryeol ^a  

^a Bugok National Hospital   (South Korea)

Author keywords

Activity; Activity tracker; Feasibility; MHealth device; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; GENERAL DEVICE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOBILE HEALTH DEVICE; NEGATIVE SYNDROME; PHYSICAL ACTIVITY; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PREDICTIVE VALUE; PRIORITY JOURNAL; SCHIZOPHRENIA; ACTIMETRY; CHRONIC DISEASE; DEVICES; EXERCISE; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TELEMEDICINE; YOUNG ADULT;

ACTIGRAPHY; ADULT; CHRONIC DISEASE; EXERCISE; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; TELEMEDICINE; YOUNG ADULT;

EID: 85006295097     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2016.10.059     Document Type: Article

References (42)

1. Bervoets, C., Docx, L., Sabbe, B., Vermeylen, S., Van Den Bossche, M.J., Morsel, A., Morrens, M., The nature of the relationship of psychomotor slowing with negative symptomatology in schizophrenia. Cogn. Neuropsychiatry 19 (2014), 36–46.
2. Bracht, T., Schnell, S., Federspiel, A., Razavi, N., Horn, H., Strik, W., Wiest, R., Dierks, T., Müller, T.J., Walther, S., Altered cortico-basal ganglia motor pathways reflect reduced volitional motor activity in schizophrenia. Schizophr. Res. 143 (2013), 269–276.
3. Cadmus-Bertram, L., Marcus, B.H., Patterson, R.E., Parker, B.A., Morey, B.L., Use of the fitbit to measure adherence to a physical activity intervention among overweight or obese, postmenopausal women: self-monitoring trajectory during 16 weeks. JMIR mhealth uhealth, 3, 2015, e96.
4. Cadmus-Bertram, L.A., Marcus, B.H., Patterson, R.E., Parker, B.A., Morey, B.L., Randomized trial of a fitbit-Based physical activity intervention for women. Am. J. Prev. Med. 49 (2015), 414–418.
5. Chalfoun, C., Karelis, A.D., Stip, E., Abdel-Baki, A., Running for your life: a review of physical activity and cardiovascular disease risk reduction in individuals with schizophrenia. J. Sports Sci., 2015, 1–16.
6. Choi, J., Lee, J.H., Vittinghoff, E., Fukuoka, Y., mHealth physical activity intervention: a randomized pilot study in physically inactive pregnant women. Matern. Child Health J., 2015.
7. Dickinson, H.O., Mason, J.M., Nicolson, D.J., Campbell, F., Beyer, F.R., Cook, J.V., Williams, B., Ford, G.A., Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J. Hypertens. 24 (2006), 215–233.
8. Docx, L., Sabbe, B., Provinciael, P., Merckx, N., Morrens, M., Quantitative psychomotor dysfunction in schizophrenia: a loss of drive, impaired movement execution or both?. Neuropsychobiology 68 (2013), 221–227.
9. Ekelund, U., Besson, H., Luan, Ja, May, A.M., Sharp, S.J., Brage, S., Travier, N., Agudo, A., Slimani, N., Rinaldi, S., Physical activity and gain in abdominal adiposity and body weight: prospective cohort study in 288498 men and women. Am. J. Clin. Nutr. 93 (2011), 826–835.
10. Fasmer, O.B., Hauge, E., Berle, J.Ø., Dilsaver, S., Oedegaard, K.J., Distribution of active and resting periods in the motor activity of patients with depression and schizophrenia. Psychiatry Investig. 13 (2016), 112–120.
11. Faulkner, G., Cohn, T., Remington, G., Validation of a physical activity assessment tool for individuals with schizophrenia. Schizophr. Res. 82 (2006), 225–231.
12. van der Gaag, M., Hoffman, T., Remijsen, M., Hijman, R., de Haan, L., van Meijel, B., van Harten, P.N., Valmaggia, L., De Hert, M., Cuijpers, A., The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model. Schizophr. Res. 85 (2006), 280–287.
13. Haskell, W.L., Lee, I.-M., Pate, R.R., Powell, K.E., Blair, S.N., Franklin, B.A., Macera, C.A., Heath, G.W., Thompson, P.D., Bauman, A., Physical activity and public health: updated recommendation for adults from the american college of sports medicine and the American Heart Association. Med. Sci. Sports Exerc. 39 (2007), 1423–1434.
14. Hennekens, C.H., Hennekens, A.R., Hollar, D., Casey, D.E., Schizophrenia and increased risks of cardiovascular disease. Am. Heart J. 150 (2005), 1115–1121.
15. Henriksen, E.J., Exercise effects of muscle insulin signaling and action invited review: effects of acute exercise and exercise training on insulin resistance. J. Appl. Physiol. 93 (2002), 788–796.
16. Kaewkannate, K., Kim, S., A comparison of wearable fitness devices. BMC Public Health, 16, 2016, 1.
17. Kane, I., Lee, H., Sereika, S., Brar, J., Feasibility of pedometers for adults with schizophrenia: pilot study. J. Psychiatr. Ment. Health Nurs. 19 (2012), 8–14.
18. Kay, S.R., Fiszbein, A., Opler, L.A., The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13 (1987), 261–276.
19. Kooiman, T.J., Dontje, M.L., Sprenger, S.R., Krijnen, W.P., van der Schans, C.P., de Groot, M., Reliability and validity of ten consumer activity trackers. BMC Sports Sci. Med. Rehabil., 7, 2015, 24.
20. Lakka, T.A., Laaksonen, D.E., Physical activity in prevention and treatment of the metabolic syndrome. Appl. Physiol. Nutr. Metab. 32 (2007), 76–88.
21. Leucht, S., Kane, J.M., Kissling, W., Hamann, J., Etschel, E., Engel, R.R., What does the PANSS mean?. Schizophr. Res. 79 (2005), 231–238.
22. Loh, S.Y., Abdullah, A., Bakar, A.K.A., Jaafar, N.R.N., Structured walking and chronic institutionalized schizophrenia inmates: a pilot RCT Study on quality of life. Glob. J. Health Sci., 8, 2016, 238.
23. Lowther, M., Mutrie, N., Loughlan, C., McFarlane, C., Development of a Scottish physical activity questionnaire: a tool for use in physical activity interventions. Br. J. Sports Med. 33 (1999), 244–249.
24. Maturi, M.S., Afshary, P., Abedi, P., Effect of physical activity intervention based on a pedometer on physical activity level and anthropometric measures after childbirth: a randomized controlled trial. BMC Pregnancy Childbirth, 2011, 11.
25. Methapatara, W., Srisurapanont, M., Pedometer walking plus motivational interviewing program for Thai schizophrenic patients with obesity or overweight: a 12-week, randomized, controlled trial. Psychiatry Clin. Neurosci. 65 (2011), 374–380.
26. Naslund, J.A., Aschbrenner, K.A., Barre, L.K., Bartels, S.J., Feasibility of popular m-health technologies for activity tracking among individuals with serious mental illness. Telemed. J. E Health 21 (2015), 213–216.
27. Nyboe, L., Vestergaard, C., Moeller, M., Lund, H., Videbech, P., Metabolic syndrome and aerobic fitness in patients with first-episode schizophrenia, including a 1-year follow-up. Schizophr. Res. 168 (2015), 381–387.
28. Oertel-Knöchel, V., Mehler, P., Thiel, C., Steinbrecher, K., Malchow, B., Tesky, V., Ademmer, K., Prvulovic, D., Banzer, W., Zopf, Y., Effects of aerobic exercise on cognitive performance and individual psychopathology in depressive and schizophrenia patients. Eur. Arch. Psychiatry Clin. Neurosci. 264 (2014), 589–604.
29. Pal, S., Cheng, C., Ho, S., The effect of two different health messages on physical activity levels and health in sedentary overweight, middle-aged women. BMC Public Health, 11, 2011, 204.
30. Ratliff, J.C., Palmese, L.B., Reutenauer, E.L., Liskov, E., Grilo, C.M., Tek, C., The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional study. Compr. Psychiatry 53 (2012), 1028–1033.
31. Richardson, C.R., Faulkner, G., McDevitt, J., Skrinar, G.S., Hutchinson, D.S., Piette, J.D., Integrating physical activity into mental health services for persons with serious mental illness. Psychiatr. Serv. 56 (2005), 324–331.
32. Rimes, R.R., de Souza Moura, A.M., Lamego, M.K., de Sa Filho, A.S., Manochio, J., Paes, F., Carta, M.G., Mura, G., Wegner, M., Budde, H., Ferreira Rocha, N.B., Rocha, J., JM, R.S.T., Arias-Carrion, O., Nardi, A.E., Yuan, T.F., Machado, S., Effects of exercise on physical and mental health, and cognitive and brain functions in schizophrenia: clinical and experimental evidence. CNS Neurol. Disord. Drug Targets 14 (2015), 1244–1254.
33. Scheewe, T., Backx, F., Takken, T., Jörg, F., Strater, Av, Kroes, A., Kahn, R., Cahn, W., Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial. Acta Psychiatr. Scand. 127 (2013), 464–473.
34. Thompson, P.D., Crouse, S.F., Goodpaster, B., Kelley, D., Moyna, N., Pescatello, L., The acute versus the chronic response to exercise. Med. Sci. Sports Exerc. 33 (2001), S438–S445.
35. Tudor-Locke, C., Craig, C.L., Brown, W.J., Clemes, S.A., De Cocker, K., Giles-Corti, B., Hatano, Y., Inoue, S., Matsudo, S.M., Mutrie, N., Oppert, J.M., Rowe, D.A., Schmidt, M.D., Schofield, G.M., Spence, J.C., Teixeira, P.J., Tully, M.A., SN, B., How many steps/day are enough for adults. Int. J. Behav. Nutr. Phys. Act., 2011, 8.
36. Walther, S., Koschorke, P., Horn, H., Strik, W., Objectively measured motor activity in schizophrenia challenges the validity of expert ratings. Psychiatry Res. 169 (2009), 187–190.
37. Walther, S., Ramseyer, F., Horn, H., Strik, W., Tschacher, W., Less structured movement patterns predict severity of positive syndrome, excitement, and disorganization. Schizophr. Bull. 40 (2014), 585–591.
38. Walther, S., Stegmayer, K., Horn, H., Razavi, N., Müller, T.J., Strik, W., Physical activity in schizophrenia is higher in the first episode than in subsequent ones. Front. Psychiatry, 2015, 5.
39. Walther, S., Federspiel, A., Horn, H., Razavi, N., Wiest, R., Dierks, T., Strik, W., Müller, T.J., Resting state cerebral blood flow and objective motor activity reveal basal ganglia dysfunction in schizophrenia. Psychiatry Res. 192 (2011), 117–124.
40. Wannamethee, S.G., Shaper, A.G., Walker, M., Changes in physical activity, mortality, and incidence of coronary heart disease in older men. Lancet 351 (1998), 1603–1608.
41. Wichniak, A., Skowerska, A., Chojnacka-Wójtowicz, J., Tafliński, T., Wierzbicka, A., Jernajczyk, W., Jarema, M., Actigraphic monitoring of activity and rest in schizophrenic patients treated with olanzapine or risperidone. J. Psychiatr. Res. 45 (2011), 1381–1386.
42. Woods, S.W., Chlorpromazine equivalent doses for the newer atypical antipsychotics. J. Clin. Psychiatry 64 (2003), 663–667.